Skip to main content
logo
Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.270
+0.020 (0.89%)
Sep 3, 2026, 4:00 PM EDT - Market closed

Jyong Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
169304----
Market Cap Growth
-96.34%-----
Enterprise Value
186322----
Last Close Price
2.273.95----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--12.20----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.74-0.74-0.50-0.49-0.48-0.50
Net Debt / Equity Ratio
-0.70-0.70-0.49-0.48-0.45-0.40
Net Debt / EBITDA Ratio
-6.93-6.93-9.32-6.18-4.97-4.12
Net Debt / FCF Ratio
-5.71-5.71-4.98-6.35-4.18-4.43
Quick Ratio
0.030.030.010.010.060.38
Current Ratio
0.450.450.020.130.190.42
Return on Assets (ROA)
-12.01%-12.01%-17.59%-20.57%-19.45%-13.49%
Return on Capital Employed (ROCE)
18.60%18.60%35.70%46.50%68.00%-76.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.77%-1.54%----
FCF Yield
-1.80%-1.00%----
Buyback Yield / Dilution
-2.02%-2.02%----
SEC Filings: 10-K · 10-Q